Identification and clinical relevance of an oxytocin-deficient state: randomized, crossover, placebo-controlled pilot physiopathological study: GLP1 Study.
This research is exploring the hormone oxytocin in individuals who have hypopituitarism, a condition where the pituitary gland doesn't produce enough hormones. We want to understand how oxytocin is released in these patients and if a medication called Byetta (or a placebo, a dummy medicine) can change its release pattern. Byetta is already used for type 2 diabetes. The study will also look at how these changes in oxytocin might link to feelings, eating habits, and overall well-being. This is an early-stage study, meaning it's one of the first steps to see if this approach could be helpful in the future.
At a glance
What is this study about?
This study is designed to learn more about a natural hormone in your body called oxytocin. Oxytocin is often linked to feelings like social bonding and trust, and it plays a role in many body functions. We're particularly interested in people with a condition called hypopituitarism. This is a rare health problem where a small gland in your brain, called the pituitary gland, doesn't make enough of certain important hormones. We want to find out if there's a specific lack of oxytocin in these individuals and what impact that might have.
The main goal of this research is to see how oxytocin is released in your body after you've been given a specific medicine called Byetta, or a dummy medicine (placebo). Byetta is a medication already approved for people with type 2 diabetes, but in this study, we're exploring a different potential use for it. We're hoping to understand the patterns of oxytocin release and whether Byetta can influence them. This is an early-stage study, meaning it's aimed at finding out basic information and exploring new ideas, rather than being a final test of a treatment.
Beyond just tracking oxytocin, we'll also be looking at how any changes might be linked to other aspects of your health. This includes your mood, how you express emotions, your eating habits, your sexual health, and your overall quality of life. By gathering all this information, researchers hope to get a clearer picture of oxytocin's role in hypopituitarism and if medicines like Byetta could one day offer a new way to help people with this condition feel better.
Key takeaways
- This study focuses on people with hypopituitarism and the hormone oxytocin.
- It tests a medicine called Byetta to see how it affects oxytocin release.
- The study also looks at how oxytocin changes might link to mood and quality of life.
- Participants will receive both the active medicine and a dummy medicine (placebo) at different times.
- It's an early-stage study, designed to learn more rather than being a final treatment test.
Who may be eligible?
This study is looking for adult participants, meaning you need to be 18 years old or older to take part. There is no upper age limit, so adults of any age are welcome to consider joining.
Both men and women are invited to participate in this research. The study isn't limited by gender, as researchers want to understand how oxytocin works in everyone.
To be considered for this study, you would need to have a diagnosis of hypopituitarism. This is a key requirement, as the research specifically focuses on understanding hormone levels and responses in people living with this particular condition. The research team will review your medical history to confirm if you meet all the necessary criteria.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have a diagnosis of hypopituitarism?
- Are you able to attend study visits as required?
- Are you willing to have blood tests and fill out questionnaires?
What does participation involve?
If you decide to take part in this study, you would receive either the study medicine, Byetta, or a dummy medicine (placebo) via an injection. This is a 'crossover' study, which means that at different times, you would receive both the active medicine and the placebo, so researchers can compare their effects in the same person. You wouldn't know which one you're receiving at any given time.
Taking part would involve several visits to the study centre. During these visits, the research team would monitor your health and take samples, likely blood tests, to measure your oxytocin levels. You would also be asked to fill out some questionnaires. These questionnaires would cover topics like your mood, how you express emotions, your eating habits, and your overall quality of life.
The total duration of your participation in the study, including all visits and follow-ups, would be explained to you in detail by the study team. They will also tell you exactly what each visit will involve and how long it might take.
Potential risks and benefits
Locations (1)
- —UnverifiedSpain
Common questions
What is oxytocin?
Oxytocin is a natural hormone in your body that has many roles, including affecting social feelings and some body functions.
What is hypopituitarism?
Hypopituitarism is a health condition where a small gland in your brain, called the pituitary gland, doesn't produce enough of certain important hormones.
What is Byetta?
Byetta is a medicine that's already approved for treating type 2 diabetes. In this study, we're looking at its effects on oxytocin.
What is a 'placebo'?
A placebo is a dummy medicine that looks just like the real medicine but contains no active ingredients. It helps researchers compare effects.
Will I know if I'm getting Byetta or the placebo?
No, this is a 'blinded' study, meaning neither you nor the researchers will know if you're receiving Byetta or the placebo at any given time.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.